| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2d2266f3e1ac82b1f11142aefec80c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 |
| filingDate |
2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba53a186a94b2edab1646c64723a914b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d1046666e46769810a25c8d569f23ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a6277c32e84d688ea3797c0474ed1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cf679f4504662976a79cc4878b848af |
| publicationDate |
2020-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2716258-C1 |
| titleOfInvention |
Peptide antagonist of the nmda receptor |
| abstract |
FIELD: pharmaceutics.SUBSTANCE: invention relates to biologically active substances of peptide nature used as an agent for treating depression, major depressive disorder, neuropathic pain and possessing neuroprotective activity. Disclosed is use of a pharmaceutical composition containing D-Phe-L-Tyr, for treating or preventing diseases mediated by excess activity of NMDA receptors. Compositions of the pharmaceutical composition can be presented in the form of a solution for injections, as well as drops in the nose.EFFECT: disclosed pharmaceutical composition can be used in medicine.1 cl, 2 dwg, 7 ex |
| priorityDate |
2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |